Table 6 Biodistribution of radioactivity after i.v. injection of 67Ga-DOTA-(L-Glu)14 in micea.
From: Evaluation of Ga-DOTA-(D-Asp)n as bone imaging agents: D-aspartic acid peptides as carriers to bone
Tissue | Time after injection | ||
|---|---|---|---|
10āmin | 60āmin | 180āmin | |
Blood | 1.85 (0.47) | 0.12 (0.04) | 0.05 (0.02) |
Liver | 0.47 (0.16) | 0.13 (0.03) | 0.14 (0.04) |
Kidney | 22.06 (4.67) | 26.41 (8.53) | 25.14 (3.75) |
Small-intestine | 0.50 (0.14) | 0.13 (0.05) | 0.15 (0.09) |
Large-intestine | 0.37 (0.13) | 0.07 (0.01) | 0.23 (0.15) |
Spleen | 0.44 (0.12) | 0.10 (0.03) | 0.11 (0.06) |
Pancreas | 0.59 (0.15) | 0.13 (0.02) | 0.08 (0.02) |
Lung | 1.57 (0.42) | 0.13 (0.03) | 0.06 (0.02) |
Heart | 0.67 (0.22) | 0.10 (0.02) | 0.06 (0.01) |
Stomachb | 0.22 (0.03) | 0.07 (0.05) | 0.07 (0.07) |
Bone (Femur) | 9.81 (2.35) | 11.07 (1.66) | 10.90 (1.17) |
Muscle | 0.63 (0.12) | 0.10 (0.05) | 0.30 (0.47) |
Brain | 0.05 (0.01) | 0.01 (0.00) | 0.03 (0.01) |
F/B ratioc | 5.41 (0.93) | 97.50 (26.27) | 239.85 (89.95) |